Talk:A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients with Type 2 Diabetes

From Pubdrug

Recommended changes

Quick Summary - Let's change this around a little to delete the wording "long-term." While a year is a pretty decent length for a study such as this, I think "long-term" is misleading. We can say "year-long" or 52 weeks - you can decide.

I took out "as defined by the National Diabetes Study Group" - it is worded oddly in the paper, but I think that "definition" is for endogenous insulin production, which you defined. A definition of Diabetes Diagnosis would likely be based on ADA criteria.

The Primary Outcome Results should be only 1-2 sentences reporting the result of the primary endpoint (in this case LVMI at weeks 28 & 52 compared with baseline). I boldfaced the sentence that should be the main point. All of the secondary endpoints and beyond should be listed as a subheading and bullet pointed for easy reading. (May look at another student's article review for heading/subheading).

According to table 3, it looks like SBP was also significantly decreased in RSG group - though I see that the abstract only mentions DBP. What do you think?

MJW to consider renaming page at some point. W 04:50, 3 May 2007 (PDT)

Peer review

Peer review signature 1:

Peer review signature 2: